Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Jan 26
Love0

The Gastrointestinal Microbiome and Immune Checkpoint Inhibitors: A Review of Human Interventional Studies Among Melanoma Patients

By Chuck Lin No Comments
INTRODUCTIONMelanoma and Immune Checkpoint Inhibitors  Melanoma is a malignant neoplasm of the melanin-producing cells residing in the basal layer of the epidermis.1 Estimations depict 21.5 new cases of cutaneous melanoma…
Read More
Jan 26
Love0

Outcomes for Psoriasis by Self-Identified Racial Groups in Ixekizumab Clinical Trials: A Pooled Analysis

By Chuck Lin No Comments
INTRODUCTIONPsoriasis is a chronic, immune-mediated skin disease affecting approximately 125 million people worldwide, with a higher reported prevalence in the White population (3.6%) than in people with skin of color…
Read More
Jan 25
Love0

A New Tool to Improve Communication Between Hidradenitis Suppurativa Patients and Health Care Providers

By Chuck Lin No Comments
INTRODUCTIONHidradenitis suppurativa (HS) is a chronic, inflammatory skin condition characterized by abscesses, nodules, fistulae, draining sinus tracts, and scarring.1 Though the pathogenesis of HS is not fully understood, the disease…
Read More
Jan 24
Love0

Topical Calcineurin Inhibitors in the Management of Chronic Pruritus in Older Adults: A Research Letter

By Chuck Lin No Comments
INTRODUCTIONChronic itch is common among older adults, however, without overt serologic or histologic abnormalities, many geriatric patients have no discernible cause of their pruritus. In these cases, it is postulated…
Read More
Jan 24
Love0

Implicit Bias and Clinical Decision Making in Psoriasis Management Among Dermatology Residents: A Feasibility Study

By Chuck Lin No Comments
Black and white individuals may not receive equal health care even when insurance status, income level, and access to health care are taken into account.1 Despite psoriasis having an established…
Read More
Jan 24
Love0

The Pediatric Dermatologist’s View of Pediatric Vitiligo

By Chuck Lin No Comments
To The Editor, Few surveyed practitioners provide medical intervention for vitiligo in the Netherlands.1 In a recent United Kingdom qualitative patient survey, patients reported that their physicians had low awareness…
Read More
Jan 24
Love0

Teledermatology Platforms Usage and Barriers: A Cross-Sectional Analysis of United States-Based Dermatologists Pre- and Post-COVID-19

By Chuck Lin No Comments
INTRODUCTIONUnited States-based dermatologists adapted to the COVID-19 public health emergency in part by integrating teledermatology into their practices.1,2 Pre-COVID-19, asynchronous or store-and-forward (SAF) teledermatology was a relatively cost-effective tool providing…
Read More
Jan 24
Love0

Tips, Trends, and Truths: A Study of Psoriasis Treatment Content on TikTok

By Chuck Lin No Comments
INTRODUCTIONSocial media is a popular source of medical information.1 Approximately 45% of individuals report that social media plays a role in their decision to seek medical care from a healthcare…
Read More
Jan 24
Love0

Cysteamine Isobionic-Amide Complex Versus Kligman’s Formula for the Treatment of Melasma: Equal Efficacy and Rapid Onset of Action

By Chuck Lin No Comments
INTRODUCTIONMelasma is an acquired, pigmentary disorder characterized by the appearance of light brown to dark macules on sun-exposed areas of the body, most commonly occurring on the face. It can…
Read More
Jan 24
Love0

Improvement of Chronic Venous Insufficiency Related Leg Xerosis and Dermatitis With Ceramide-Containing Cleansers and Moisturizers: An Expert-Based Consensus

By Chuck Lin No Comments
INTRODUCTIONChronic venous insufficiency (CVI) comprises structural and functional pathology of the venous system. CVIs' pathophysiology most commonly results from lower extremity valvular reflux and/or venous obstruction, which induces sustained elevated…
Read More
Jan 20
Love0

Number of Affected Nails Is the Primary Determinant of Efinaconazole 10% Solution Usage for Onychomycosis

By Chuck Lin No Comments
INTRODUCTIONTopical onychomycosis therapies require extended treatment durations, and incomplete treatment can contribute to high relapse rates.1 Excellent treatment adherence is vital to optimize outcomes2 and requires that an adequate quantity…
Read More
Jan 20
Love0

Atypical Dyschromia in Skin of Color

By Chuck Lin No Comments
INTRODUCTIONDyschromia is often the result of an external or internal insult to the skin.1 It is a concern for many patients, especially persons of color.2,3 In black patients, dyschromia is…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors May 23, 2025
  • A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis May 22, 2025
  • Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study May 21, 2025
  • JDD in the News: Upadacitinib’s Potential Cardiovascular Effects  May 21, 2025
  • Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares May 20, 2025

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |      ADVERTISING POLICY

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2025 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search